Posted 10 January, 2023
iSpecimen Inc. appointed Tracy Curley as new CEO
Nasdaq:ISPC appointed new Chief Executive Officer Tracy Curley in a 8-K filed on 10 January, 2023.
The Board appointed Tracy Curley, who concurrently serves as the Chief Financial Officer and Treasurer of the Company, as Interim Chief Executive Officer of the Company, effective immediately upon Dr. Ianelli's no longer serving as Chief Executive Officer and President of the Company.
Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of iSpecimen Inc.
None • None
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in July 2009 and is headquartered in Lexington, MA.Market Cap
$4.25M
View Company Details
$4.25M
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed in the Current Report on the Form 8-K of iSpecimen Inc., a Delaware corporation (the "Company"), filed with the Securities and Exchange Commission on September 22, 2022, Christopher Ianelli informed the Board of Directors (the "Board") of the Company of his intention to resign as Chief Executive Officer and President of the Company effective October 24, 2022. As a result. The Board appointed Tracy Curley, who concurrently serves as the Chief Financial Officer and Treasurer of the Company, as Interim Chief Executive Officer of the Company, effective immediately upon Dr. Ianelli's no longer serving as Chief Executive Officer and President of the Company. On January 9, 2023, the Board, at a Special Meeting of the Board of Directors, appointed Ms. Curley as Chief Executive Officer of the Company, effective immediately. With the appointment of Ms. Curley as Chief Executive Officer, the Board will be initiating a comprehensive search process to identify a new Chief Financial Officer of the Company. Ms. Curley has been serving as Chief Financial Officer of the Company since August 2020 and as Treasurer of the Company since July 2021. She was a partner at Cohn Reznick LLP, a national accounting firm, from September 2017 to June 2020. During her time at CohnReznick, LLP, Ms. Curley led the creation and development of an emerging markets commercial audit practice for the firm in their Boston, MA office. Her practice focused on recruiting and providing audit services to private and public emerging growth companies in the technology and life sciences industries. From November 2014 to August 2017, she also served as a partner at Marcum LLP, a national accounting firm. Ms. Curley led the northeast regional high-tech practice for the firm. She focused on expanding the client base to provide a full range of accounting, tax and advisory services for private and public emerging growth companies in high tech industries such as technology, life sciences and advanced manufacturing. From March 2010 to October 2014, Ms. Curley served as a partner at Moody, Famiglietti & Andronico, LLP ("MFA"), a proactive consulting firm in the greater Boston, MA area with national and global reach. During her time at MFA, Ms. Curley led the creation and development of a public company audit practice focused on recruiting and providing audit services to public emerging growth companies. Ms. Curley serves as President and a board member of the North Shore Technology Council and as a board member of Project Green Schools. Ms. Curley received her Master of Accountancy and Bachelor of Science in Business Administration with a concentration in accounting from Kansas State University. She also attended the United States Military Academy. She is a certified public accountant licensed in the Commonwealth of Massachusetts. There are no family relationships between Ms. Curley and any director, executive officer, or person nominated or chosen by the Company to become an executive officer of the Company. There are no transactions between the Company and Ms. Curley that are subject to disclosure under Item 404(a) of Regulation S-K. On January 10, 2023, the Company issued a press release announcing the appointment of Ms. Curley. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.